Fibrates and high-dose statins to prevent coronary heart disease events

被引：1

作者：

Jones P.H. ^{[1
]}

机构：

[1] Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston

来源：

Current Cardiology Reports | 1999年 / 1卷 / 3期

关键词：

Atorvastatin; Bezafibrate; Coronary Heart Disease Event; Postprandial Lipemia; Bezafibrate Infarction Prevention;

D O I：

10.1007/s11886-999-0026-8

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：223 / 224

页数：1

共 5 条

[1]

Grundy, S.M., Statin trials and goals of cholesterol lowering therapy (1998) Circulation, 97, pp. 1436-1439

[2]

Libby, P., Molecular basis of the acute coronary syndromes (1995) Circulation, 91, pp. 2844-2850

[3]

Rosenson, R.S., Tangney, C.C., Antiatherothrom botic properties of statins (1998) JAMA, 279, pp. 1643-1650

[4]

Hodis, H., Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis (1999) Circulation, 99, pp. 2852-2854

[5]

Pitt, B., Waters, D., Brown, W.V., Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease (1999) N Engl J Med, 341, pp. 70-76

← 1 →